doi:10.1016/j.virs.2022.09.008

[1]
Xiao-Li Feng, Dandan Yu, Mi Zhang, Xiaohong Li, Qing-Cui Zou, Wentai Ma, Jian-Bao Han, Ling Xu, Cuixian Yang, Wang Qu, Zhong-Hua Deng, Junyi Long, Yanghaopeng Long, Mingkun Li, Yong-Gang Yao, Xing-Qi Dong, Jianxiong Zeng, Ming-Hua Li, 2022: Characteristics of replication and pathogenicity of SARS-CoV-2 Alpha and Delta isolates, Virologica Sinica, 37, 804-812. doi: 10.1016/j.virs.2022.09.007
[2]
Serkan Öncü, 2013: Crimean-Congo Hemorrhagic Fever: An Overview, Virologica Sinica, 28, 193-201. doi: 10.1007/s12250-013-3327-4
[3]
贾丽丽, 郑铮, 俞永新, 1993: Pathogenicity and Immunogenicity of Attenuated Japanese Encephalitis Vaccine (SA_(14)-14-2) in Immune-Inhibited Mice, Virologica Sinica, 8, 20-.
[4]
Kaituo Liu, Yaqian Guo, Huafen Zheng, Zhuxing Ji, Miao Cai, Ruyi Gao, Pinghu Zhang, Xiaowen Liu, Xiulong Xu, Xiaoquan Wang, Xiufan Liu, 2023: Enhanced pathogenicity and transmissibility of H9N2 avian influenza virus in mammals by hemagglutinin mutations combined with PB2-627K, Virologica Sinica, 38, 47-55. doi: 10.1016/j.virs.2022.09.006
[5]
Wei Yang, Songliu Yang, Lei Wang, Yuxin Zhou, Yu Xin, Hongxu Li, Wenjing Mu, Qi Wu, Lei Xu, Mingyan Zhao, Changsong Wang, Kaijiang Yu, 2022: Clinical characteristics of 310 SARS-CoV-2 Omicron variant patients and comparison with Delta and Beta variant patients in China, Virologica Sinica, 37, 704-715. doi: 10.1016/j.virs.2022.07.014
[6]
Yang Li, Hao-Rui Si, Yan Zhu, Nan Xie, Bei Li, Xiang-Ping Zhang, Jun-Feng Han, Hong-Hong Bao, Yong Yang, Kai Zhao, Zi-Yuan Hou, Si-Jia Cheng, Shuan-Hu Zhang, Zheng-Li Shi, Peng Zhou, 2022: Characteristics of SARS-CoV-2 transmission in a medium-sized city with traditional communities during the early COVID-19 epidemic in China, Virologica Sinica, 37, 187-197. doi: 10.1016/j.virs.2022.01.030
[7]
Qianran Wang, Lu Peng, Yanqiu Nie, Yanni Shu, Huajun Zhang, Zidan Song, Yufeng Li, Hengrui Hu, Liushuai Li, Xi Wang, Jia Liu, Jiang Li, Zhengli Shi, Fei Deng, Yu Guo, Yiwu Zhou, Bing Yan, Zhihong Hu, Manli Wang, 2023: Hybridoma-derived neutralizing monoclonal antibodies against Beta and Delta variants of SARS-CoV-2 in vivo, Virologica Sinica, 38, 257-267. doi: 10.1016/j.virs.2022.12.007
[8]
Jingchuan Yin, Shi Liu, Ying Zhu, 2013: An Overview of the Highly Pathogenic H5N1 Influenza Virus, Virologica Sinica, 28, 3-15. doi: 10.1007/s12250-013-3294-9
[9]
Sissy Therese Sonnleitner, Stefanie Sonnleitner, Eva Hinterbichler, Hannah Halbfurter, Dominik B.C. Kopecky, Stephan Koblmüller, Christian Sturmbauer, Wilfried Posch, Gernot Walder, 2022: The mutational dynamics of the SARS-CoV-2 virus in serial passages in vitro, Virologica Sinica, 37, 198-207. doi: 10.1016/j.virs.2022.01.029
[10]
Kai Wu, Dehe Wang, Junhao Wang, Yu Zhou, 2022: Translation landscape of SARS-CoV-2 noncanonical subgenomic RNAs, Virologica Sinica, 37, 813-822. doi: 10.1016/j.virs.2022.09.003
[11]
Wei Chen, Pengmian Feng, Kewei Liu, Meng Wu, Hao Lin, 2020: Computational Identification of Small Interfering RNA Targets in SARS-CoV-2, Virologica Sinica, 35, 359-361. doi: 10.1007/s12250-020-00221-6
[12]
Chunchen Wu, Wenzhong Yang, Xiaoxue Wu, Tianzhu Zhang, Yaoyao Zhao, Wei Ren, Jianbo Xia, 2020: Clinical Manifestation and Laboratory Characteristics of SARS-CoV-2 Infection in Pregnant Women, Virologica Sinica, 35, 305-310. doi: 10.1007/s12250-020-00227-0
[13]
Bei Wang, Chongyang Zhang, Xiaobo Lei, Lili Ren, He Huang, Jianwei Wang, Zhendong Zhao, 2021: Construction of Non-infectious SARS-CoV-2 Replicons and Their Application in Drug Evaluation, Virologica Sinica, 36, 890-900. doi: 10.1007/s12250-021-00369-9
[14]
Tiandan Xiang, Junzhong Wang, Xin Zheng, 2022: The humoral and cellular immune evasion of SARS-CoV-2 Omicron and sub-lineages, Virologica Sinica, 37, 786-795. doi: 10.1016/j.virs.2022.11.007
[15]
Yi Yan, Ke Wu, Jun Chen, Haizhou Liu, Yi Huang, Yong Zhang, Jin Xiong, Weipeng Quan, Xin Wu, Yu Liang, Kunlun He, Zhilong Jia, Depeng Wang, Di Liu, Hongping Wei, Jianjun Chen, 2021: Rapid Acquisition of High-Quality SARS-CoV-2 Genome via Amplicon-Oxford Nanopore Sequencing, Virologica Sinica, 36, 901-912. doi: 10.1007/s12250-021-00378-8
[16]
Yuqi Zhu, Xinyi Yang, Jingna Xun, Jun Liu, Qing Wen, Yixiao Lin, Xiaoting Shen, Jun Chen, Songhua Yuan, Xiaying Zhao, Jing Wang, Hanyu Pan, Jinlong Yang, Zhiming Liang, Yue Liang, Qinru Lin, Huitong Liang, Min Li, Jianping Liu, Yinzhong Shen, Xiaoyan Zhang, Pengfei Wang, Daru Lu, Chunhua Yin, Jianqing Xu, Shibo Jiang, Hongzhou Lu, Huanzhang Zhu, 2022: Neutralization of five SARS-CoV-2 variants of concern by convalescent and BBIBP-CorV vaccinee serum, Virologica Sinica, 37, 831-841. doi: 10.1016/j.virs.2022.10.006
[17]
Xiaohui Zou, Shengrui Mu, Yeming Wang, Li Guo, Lili Ren, Xiaoyan Deng, Haibo Li, Jiankang Zhao, Yulin Zhang, Hui Li, Binghuai Lu, Chaolin Huang, Bin Cao, 2022: Characterization of two SARS-CoV-2 subgenomic RNA dynamics in severe COVID-19 patients, Virologica Sinica, 37, 30-37. doi: 10.1016/j.virs.2022.01.008
[18]
Changhua Yi, Yongxiang Yi, Junwei Li, 2020: mRNA Vaccines: Possible Tools to Combat SARS-CoV-2, Virologica Sinica, 35, 259-262. doi: 10.1007/s12250-020-00243-0
[19]
Pingping Yao, Yachun Zhang, Yisheng Sun, Yulin Gu, Fang Xu, Bo Su, Chen Chen, Hangjing Lu, Dehui Wang, Zhangnv Yang, Biao Niu, Jiancai Chen, Lixia Xie, Lei Chen, Yajing Zhang, Hui Wang, Yuying Zhao, Yue Guo, Juncheng Ruan, Zhiyong Zhu, Zhenfang Fu, Dayong Tian, Qi An, Jianmin Jiang, Hanping Zhu, 2020: Isolation and Growth Characteristics of SARS-CoV-2 in Vero Cell, Virologica Sinica, 35, 348-350. doi: 10.1007/s12250-020-00241-2
[20]
Yongran Wu, Ke Hong, Lianguo Ruan, Xiaobo Yang, Jiancheng Zhang, Jiqian Xu, Shangwen Pan, Lehao Ren, Lu Chen, Chaolin Huang, You Shang, 2020: Patients with Prolonged Positivity of SARS-CoV-2 RNA Benefit from Convalescent Plasma Therapy: A Retrospective Study, Virologica Sinica, 35, 768-775. doi: 10.1007/s12250-020-00281-8